Molecular imaging probes for 31P contrast

Molecular imaging probes for 31P contrast

<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Tear, L
Altri autori:	Faulkner, S
Natura:	Tesi
Lingua:	English
Pubblicazione:	2018
Soggetti:	Contrast media (Diagnostic imaging) Nuclear magnetic resonance spectroscopy Gadolinium

Documenti analoghi

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
di: T Mortezazadeh, et al.
Pubblicazione: (2020-02-01)

Magnetic Resonance Imaging Contrast Agents: A Review of Literature
di: Zahra Sahraei, et al.
Pubblicazione: (2015-10-01)

Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
di: Marco Moscatelli, et al.
Pubblicazione: (2023-10-01)

Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
di: Caterina Beatrice Monti, et al.
Pubblicazione: (2020-04-01)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
di: Simona Bussi, et al.
Pubblicazione: (2020-02-01)

Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
di: Johannes M. Froehlich, et al.
Pubblicazione: (2023-04-01)

Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
di: Nacif Marcelo S, et al.
Pubblicazione: (2012-02-01)

Toxicity associated with gadolinium-based contrast-enhanced examinations
di: Silvia Maria Lattanzio
Pubblicazione: (2021-05-01)

Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
di: V. O. Panov, et al.
Pubblicazione: (2016-09-01)

Gadolinium Deposition in the Brain and Body
di: Aart J. van der Molen
Pubblicazione: (2019-11-01)

Contrast‐Enhanced Cardiac Magnetic Resonance Imaging With a Manganese‐Based Alternative to Gadolinium for Tissue Characterization of Acute Myocardial Infarction
di: Benjamin P. Bonner, et al.
Pubblicazione: (2023-04-01)

Gadolinium retention after contrast-enhanced magnetic resonance imaging: A narrative review
di: Afnan Fahd Al-Muhanna
Pubblicazione: (2022-01-01)

The safety of magnetic resonance imaging contrast agents
di: Amy Cunningham, et al.
Pubblicazione: (2024-08-01)

Novel MR imaging contrast agents for cancer detection
di: Daryoush Shahbazi-Gahrouei
Pubblicazione: (2009-05-01)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
di: Jan M. Brendel, et al.
Pubblicazione: (2023-05-01)

THE USE OF INNOVATIVE DOMESTIC CONTRAST AGENT GADOLINIUM-BASED FOR MR-CANCER DIAGNOSIS IN EXPERIMENT
di: V. I. Chernov, et al.
Pubblicazione: (2016-02-01)

Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection
di: Valentina Visani, et al.
Pubblicazione: (2024-02-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
di: Atiya Fatima, et al.
Pubblicazione: (2021-09-01)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
di: Rong Lu, et al.
Pubblicazione: (2020-12-01)

A rare case of acute respiratory distress syndrome caused by use of gadolinium‐based magnetic resonance imaging contrast media
di: Yi Lee, et al.
Pubblicazione: (2019-11-01)

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
di: Xiaodong Li, et al.
Pubblicazione: (2020-11-01)

Dynamic nuclear polarisation as a probe of metabolism in pathophysiology
di: Miller, J
Pubblicazione: (2015)

Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
di: S A. Aleksandrova, et al.
Pubblicazione: (2024-12-01)

Gadolinium-Cyclic 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Click-Sulfonyl Fluoride for Probing Serine Protease Activity in Magnetic Resonance Imaging
di: Phuong Tu Huynh, et al.
Pubblicazione: (2023-04-01)

Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study
di: Jarl Åsbjørn Jakobsen, et al.
Pubblicazione: (2021-04-01)

Nephrogenic systemic fibrosis: Current concepts
di: Prasanta Basak, et al.
Pubblicazione: (2011-01-01)

The Use of Gadolinium in Musculoskeletal MRI—Time to Rethink?
di: Arwa Elawad, et al.
Pubblicazione: (2021-07-01)

Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy – An investigation of chelate stability using relaxometry
di: Faisal Mahmood, et al.
Pubblicazione: (2022-01-01)

MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?
di: E. S. Kamyshova, et al.
Pubblicazione: (2019-03-01)

Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
di: Bang J. Guo, et al.
Pubblicazione: (2018-09-01)

Fluorinated Paramagnetic Complexes: Sensitive and Responsive Probes for Magnetic Resonance Spectroscopy and Imaging
di: Katie L. Peterson, et al.
Pubblicazione: (2018-05-01)

Absolute quantification of human in vivo hepatic 31P magnetic resonance spectroscopy at 7 tesla
di: Purvis, L
Pubblicazione: (2018)

Molecular Dynamics Simulations of the Internal Mobility of Gd3+-Based MRI Contrast Agents: Consequences for Water Proton Relaxivity
di: Alain Borel, et al.
Pubblicazione: (2004-04-01)

31P nuclear magnetic resonance study on binary germanium phosphate glasses /
di: 218458 Abdel Wahab Mohamed Ali Hussein, et al.
Pubblicazione: (2002)

Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol
di: Moreno Zanardo, et al.
Pubblicazione: (2023-05-01)

Effects of chemical forms of gadolinium on the spleen in mice after single intravenous administration
di: Ryosuke Nakamura, et al.
Pubblicazione: (2022-03-01)

Unusual Magnetic Resonance Imaging Findings Contrast-induced Encephalopathy following Cerebral Angiography
di: Won Ho Cho, et al.
Pubblicazione: (2021-12-01)

Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions
di: Wenjie Tang, et al.
Pubblicazione: (2025-02-01)

AI-powered contrast-free cardiovascular magnetic resonance imaging for myocardial infarction
di: Vedat Cicek, et al.
Pubblicazione: (2024-11-01)

A five-year-old boy with anaphylaxis reaction to gadolinium-based MR contrast medium: a case report
di: Seung Hun Woo, et al.
Pubblicazione: (2024-10-01)